Navigation Links
Fluoride Treatment of Synthetic Bio-material Assists Dental Bone Regeneration
Date:5/2/2013

Lawrence, KS (PRWEB) May 03, 2013

Journal of Oral Implantology – For a successful dental implant, a sufficient amount of jawbone is necessary. Deficient bone must be built up before the procedure. Guided bone regeneration is a common treatment, and bio-materials treated with fluoride are displaying cell proliferation that can improve this process.

The Journal of Oral Implantology reports on a study of bio-resorbable synthetic hydroxyapatite granules used as a bone supplement material. When these granules were exposed to a 4 percent sodium fluoride solution, cell proliferation was increased.

Bone regeneration techniques include the use of artificial materials such as hydroxyapatite and tricalcium phosphate. Implant products are being made with surface coatings or textures that have a biological effect on protein attachment and cell proliferation. When fluoride is added to this surface, it activates osteoblastic, or bone-making, cells and increases the rate of bone regeneration.

In this study, hydroxyapatite granules were treated with a neutral 4 percent sodium fluoride solution. This led to the formation of a reactant resembling calcium fluoride on the surface of the granules. Immediate but slow release of fluoride came from the granules, and the concentration increased over time. Migration of human osteoblast-like MG-63 cells was confirmed when compared to a nonfluoridated control sample.

Fluoride concentrations of 1.0-2.0 parts per million (ppm) showed this positive effect. When the concentration reached 5.0 ppm, however, the opposite effect was observed—the fluoride significantly inhibited cell proliferation.

The authors conclude that the fluoride solution stimulates bone regeneration. The slow release of fluoride from hydroxyapatite granules facilitates osteogenesis, making this a beneficial method to supply fluoride and promote cell proliferation.

Full text of the article, “Fluoride-Treated Bio-Resorbable Synthetic Hydroxyapatite Promotes Proliferation and Differentiation of Human Osteoblastic MG-63 Cells,” Journal of Oral Implantology, Vol. 39, No.1, 2013, is available at http://www.joionline.org/doi/full/10.1563/AAID-JOI-D-10-00175.

###

About Journal of Oral Implantology
The Journal of Oral Implantology is the official publication of the American Academy of Implant Dentistry and of the American Academy of Implant Prosthodontics. It is dedicated to providing valuable information to general dentists, oral surgeons, prosthodontists, periodontists, scientists, clinicians, laboratory owners and technicians, manufacturers, and educators. The JOI distinguishes itself as the first and oldest journal in the world devoted exclusively to implant dentistry. For more information about the journal or society, please visit: http://www.joionline.org

Media Contact:
Bridget Lamb
Allen Press, Inc.
800/627-0326 ext. 248
blamb(at)allenpress(dot)com

Read the full story at http://www.prweb.com/releases/2013/5/prweb10682953.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Removing Fluoride: What's the Fuss?
2. Zion Health’s Native Remedy-Natural Clay Toothpaste without Fluoride; Now Available at Marquette Food Co-op
3. Zion Health Announces Native Remedy-Natural Clay Toothpaste without Fluoride formulated to help Prevent Gum Disease. Now Available At Whole Foods Market in Lafayette, CA.
4. Jacksonville, FL Periodontist, Dr. Richard E. Aguila, Offers Laser Gum Disease Treatment
5. Girls With Autism May Need Different Treatments Than Boys
6. Large genomic study identifies endometrial cancer subtypes, treatment opportunities
7. Women's Excellence in Menopause Now Offering Treatment Options for Decreased Sex Drive near Rochester Hills, Michigan; Natural Therapy Available via Bioidentical Hormones
8. Gastric bypass findings could lead to diabetes treatment
9. Into Action Drug Treatment Center Supports the March of Dimes Walk
10. Alzheimer's Treatment Clinical Trial Receives Clearance
11. Atlantic Spine Center Announces Updated Web Content on Spinal Stenosis New Treatments and a Better Approach to Spinal Stenosis Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/18/2017)... ... August 18, 2017 , ... “Emotions are sacred, valid, honored, encouraged. This ... positive education company Generation Mindful. To help change the mindset of parents and educators ... skills, she created the Time-In Toolkit, which launched on Kickstarter 3 weeks ago and ...
(Date:8/18/2017)... (PRWEB) , ... August 18, 2017 , ... Alcovit, a ... to ramp up its marketing efforts with its product now available through Jet.com. ... to the public. The effervescent powdered drink is designed to quickly detox the body ...
(Date:8/18/2017)... ... ... “Our Mountains to Climb: A Journey of Love and Faith Through Trials”: ... faith they shared to overcome struggles in life. “Our Mountains to Climb: A Journey ... Corcoran, a retired teacher and happily married since 1999; the author’s personal experiences drive ...
(Date:8/18/2017)... ... ... “Beyond Our Imaginations: The Infinite God”: shows the importance of God in living ... of published author, Mark Lawrence, born in Michigan, the author has lived in various ... greater man of God is that I have to be more mindful of feminine ...
(Date:8/18/2017)... ... ... Mandate for Kingdom Builders”: a call to walk as citizens of the Kingdom and ... published author, John F. McGeorge, Jr. Dr. John F. McGeorge Jr., B.A., J.D., ... three decades training pastors and Christian leaders. He also met his wife, Valerija, ...
Breaking Medicine News(10 mins):
(Date:8/7/2017)... , Aug. 7, 2017  Endo International plc ... reached agreements to resolve virtually all known U.S. mesh ... discussions to resolve the known remaining U.S. claims at ... payments beginning in the fourth quarter of 2017 and ... of its second quarter 2017 results, the Company intends ...
(Date:8/4/2017)... Aug. 3, 2017  Agragen, LLC, a ... in the biopharmaceutical, nutraceutical, and aquacultural feed sectors, ... its lead drug candidates, AGR131.  This drug is ... from the blood of patients suffering from inflammatory ... bowel disease. ...
(Date:8/2/2017)... Aug. 2, 2017 Fenita J. ... as a Pinnacle Lifetime Professional in the Field ... Manager at Turing Pharmaceuticals, AG. Her skills and ... relationship building.                ... 25 years of experience as a highly successful ...
Breaking Medicine Technology: